- Home
- RNTX vs ICMB Comparison
RNTX vs ICMB Comparison
Compare RNTX & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNTX
- ICMB
- Stock Information
- Founded
- RNTX 2001
- ICMB 2012
- Country
- RNTX United States
- ICMB United States
- Employees
- RNTX N/A
- ICMB N/A
- Industry
- RNTX Biotechnology: Pharmaceutical Preparations
- ICMB Finance: Consumer Services
- Sector
- RNTX Health Care
- ICMB Finance
- Exchange
- RNTX Nasdaq
- ICMB Nasdaq
- Market Cap
- RNTX 44.2M
- ICMB 44.8M
- IPO Year
- RNTX N/A
- ICMB N/A
- Fundamental
- Price
- RNTX $1.74
- ICMB $3.21
- Analyst Decision
- RNTX
- ICMB
- Analyst Count
- RNTX 0
- ICMB 0
- Target Price
- RNTX N/A
- ICMB N/A
- AVG Volume (30 Days)
- RNTX 25.1K
- ICMB 19.6K
- Earning Date
- RNTX 05-14-2025
- ICMB 03-25-2025
- Dividend Yield
- RNTX N/A
- ICMB 14.83%
- EPS Growth
- RNTX N/A
- ICMB N/A
- EPS
- RNTX N/A
- ICMB 0.45
- Revenue
- RNTX N/A
- ICMB $23,360,165.00
- Revenue This Year
- RNTX N/A
- ICMB N/A
- Revenue Next Year
- RNTX N/A
- ICMB N/A
- P/E Ratio
- RNTX N/A
- ICMB $7.17
- Revenue Growth
- RNTX N/A
- ICMB N/A
- 52 Week Low
- RNTX $1.61
- ICMB $2.91
- 52 Week High
- RNTX $7.42
- ICMB $3.67
- Technical
- Relative Strength Index (RSI)
- RNTX N/A
- ICMB 50.05
- Support Level
- RNTX N/A
- ICMB $3.14
- Resistance Level
- RNTX N/A
- ICMB $3.30
- Average True Range (ATR)
- RNTX 0.00
- ICMB 0.09
- MACD
- RNTX 0.00
- ICMB -0.01
- Stochastic Oscillator
- RNTX 0.00
- ICMB 36.76
About RNTX Rein Therapeutics Inc. Common Stock
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.